FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200561142> ?p ?o ?g. }

• W3200561142 abstract "Background: Primary hyperoxaluria type 1 (PH1) is a rare genetic disease that can result in irreversible damage to the kidneys and, eventually, extrarenal organs. While kidney failure is a known consequence of PH1, few studies to date have characterized clinical consequences of PH1 prior to kidney failure, and data on healthcare resource use outcomes across different stages of disease severity in PH1 are also limited. To help fill this knowledge gap, this study characterized the clinical and healthcare resource use (HRU) burden in patients with PH1 with varying stages of kidney disease. Methods: Nephrologists in the United States, Canada, United Kingdom, France, Germany, and Italy abstracted chart data from patients with PH1 under their care via an online questionnaire. Eligible patients had confirmed PH1 and ≥2 office visits from 2016 to 2019. Results: A total of 120 patients were analyzed (median age at diagnosis, 17.4 years old, median age at index 19.5 years old, median eGFR at index 45 ml/min/1.73 m 2 ; median follow-up 1.7 years). During follow-up, the most common PH1 manifestations were kidney stones and urinary tract infections (UTIs, both 56.8%), and the most common symptoms were fatigue/weakness (71.7%) and pain (64.6%). With regard to HRU during follow-up, 37.4% required lithotripsy, 31.3% required ureteroscopy, and 9.6% required nephrolithotomy. PH1-related hospitalizations and emergency/urgent care visits were noted for 84.0 and 81.6% of patients, respectively. Conclusions: The current study demonstrated that patients with PH1 across various stages of kidney disease exhibited a substantial clinical burden, including kidney stones, UTIs, fatigue/weakness, and pain, and required frequent HRU, including kidney stone procedures, hospitalizations, and emergency visits. These findings highlight the significant morbidity and HRU burden in patients with PH1." @default.
• W3200561142 created "2021-09-27" @default.
• W3200561142 creator A5000037287 @default.
• W3200561142 creator A5000970532 @default.
• W3200561142 creator A5010007260 @default.
• W3200561142 creator A5013701865 @default.
• W3200561142 creator A5018831744 @default.
• W3200561142 creator A5019956913 @default.
• W3200561142 creator A5021139854 @default.
• W3200561142 creator A5021604960 @default.
• W3200561142 creator A5043168624 @default.
• W3200561142 creator A5045788682 @default.
• W3200561142 date "2021-09-20" @default.
• W3200561142 modified "2023-10-16" @default.
• W3200561142 title "Primary Hyperoxaluria Type 1 Disease Manifestations and Healthcare Utilization: A Multi-Country, Online, Chart Review Study" @default.
• W3200561142 cites W1897834913 @default.
• W3200561142 cites W1963912010 @default.
• W3200561142 cites W1973114269 @default.
• W3200561142 cites W1977400880 @default.
• W3200561142 cites W1980122941 @default.
• W3200561142 cites W1984393349 @default.
• W3200561142 cites W1991812607 @default.
• W3200561142 cites W1998256510 @default.
• W3200561142 cites W2012590554 @default.
• W3200561142 cites W2022227993 @default.
• W3200561142 cites W2032610564 @default.
• W3200561142 cites W2047836558 @default.
• W3200561142 cites W2056283844 @default.
• W3200561142 cites W2067461070 @default.
• W3200561142 cites W2074719424 @default.
• W3200561142 cites W2075121105 @default.
• W3200561142 cites W2081483685 @default.
• W3200561142 cites W2084632490 @default.
• W3200561142 cites W2087010268 @default.
• W3200561142 cites W2092427005 @default.
• W3200561142 cites W2106951882 @default.
• W3200561142 cites W2109644074 @default.
• W3200561142 cites W2139069224 @default.
• W3200561142 cites W2353304392 @default.
• W3200561142 cites W2739615766 @default.
• W3200561142 cites W2766366998 @default.
• W3200561142 cites W2895204848 @default.
• W3200561142 cites W2901274586 @default.
• W3200561142 cites W2908800899 @default.
• W3200561142 cites W3010992580 @default.
• W3200561142 cites W3015314182 @default.
• W3200561142 cites W3151149834 @default.
• W3200561142 cites W4236938577 @default.
• W3200561142 doi "https://doi.org/10.3389/fmed.2021.703305" @default.
• W3200561142 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8488346" @default.
• W3200561142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34616753" @default.
• W3200561142 hasPublicationYear "2021" @default.
• W3200561142 type Work @default.
• W3200561142 sameAs 3200561142 @default.
• W3200561142 citedByCount "3" @default.
• W3200561142 countsByYear W32005611422023 @default.
• W3200561142 crossrefType "journal-article" @default.
• W3200561142 hasAuthorship W3200561142A5000037287 @default.
• W3200561142 hasAuthorship W3200561142A5000970532 @default.
• W3200561142 hasAuthorship W3200561142A5010007260 @default.
• W3200561142 hasAuthorship W3200561142A5013701865 @default.
• W3200561142 hasAuthorship W3200561142A5018831744 @default.
• W3200561142 hasAuthorship W3200561142A5019956913 @default.
• W3200561142 hasAuthorship W3200561142A5021139854 @default.
• W3200561142 hasAuthorship W3200561142A5021604960 @default.
• W3200561142 hasAuthorship W3200561142A5043168624 @default.
• W3200561142 hasAuthorship W3200561142A5045788682 @default.
• W3200561142 hasBestOaLocation W32005611421 @default.
• W3200561142 hasConcept C126322002 @default.
• W3200561142 hasConcept C160735492 @default.
• W3200561142 hasConcept C162324750 @default.
• W3200561142 hasConcept C177713679 @default.
• W3200561142 hasConcept C187212893 @default.
• W3200561142 hasConcept C194828623 @default.
• W3200561142 hasConcept C2778653478 @default.
• W3200561142 hasConcept C2779134260 @default.
• W3200561142 hasConcept C2779403450 @default.
• W3200561142 hasConcept C2780091579 @default.
• W3200561142 hasConcept C2781092957 @default.
• W3200561142 hasConcept C50522688 @default.
• W3200561142 hasConcept C71924100 @default.
• W3200561142 hasConcept C77411442 @default.
• W3200561142 hasConceptScore W3200561142C126322002 @default.
• W3200561142 hasConceptScore W3200561142C160735492 @default.
• W3200561142 hasConceptScore W3200561142C162324750 @default.
• W3200561142 hasConceptScore W3200561142C177713679 @default.
• W3200561142 hasConceptScore W3200561142C187212893 @default.
• W3200561142 hasConceptScore W3200561142C194828623 @default.
• W3200561142 hasConceptScore W3200561142C2778653478 @default.
• W3200561142 hasConceptScore W3200561142C2779134260 @default.
• W3200561142 hasConceptScore W3200561142C2779403450 @default.
• W3200561142 hasConceptScore W3200561142C2780091579 @default.
• W3200561142 hasConceptScore W3200561142C2781092957 @default.
• W3200561142 hasConceptScore W3200561142C50522688 @default.
• W3200561142 hasConceptScore W3200561142C71924100 @default.
• W3200561142 hasConceptScore W3200561142C77411442 @default.
• W3200561142 hasFunder F4320309056 @default.
• W3200561142 hasLocation W32005611421 @default.
• W3200561142 hasLocation W32005611422 @default.
• W3200561142 hasLocation W32005611423 @default.

• next